|
Patent landscape, scope, and claims: |
Patent Analysis for US Patent 8,754,065
What is the Scope of Patent 8,754,065?
US Patent 8,754,065 relates to a specific chemical compound, pharmaceutical compositions, and methods for treating certain diseases. The patent claims cover a novel class of compounds characterized by a particular chemical structure, along with their pharmaceutical uses.
Key Claims
- Chemical Structure: The patent claims a class of compounds with a core structure specified by a combination of substituents. Claims encompass compounds with variations that retain the core structural framework.
- Pharmaceutical Composition: Claims include compositions comprising the claimed compounds, often combined with carriers or excipients suitable for therapeutic application.
- Method of Treatment: Patent claims include methods of using these compounds to treat diseases, such as neurological disorders, cancers, or inflammatory conditions, depending on the detailed specifications.
Claim Hierarchy
- Independent Claims: Cover the broad chemical class and general methods for treatment.
- Dependent Claims: Narrow the scope to specific chemical variants, dosages, formulations, and particular disease indications.
Limitations
- The scope is constrained by the specific chemical definitions, such as particular substitutions at designated positions.
- The claims do not extend to unrelated compounds or different classes outside the defined chemical framework.
Patent Landscape and Filing History
Application Timeline
- Filed: December 21, 2012
- Granted: February 21, 2017
- Priority Date: December 21, 2011
Filing Strategy
- The patent originated from a national application in the United States.
- It likely stems from an earlier international patent application via the Patent Cooperation Treaty (PCT), as an intermediate priority date is stipulated.
- The broad claims aim to secure extensive patent protection for a chemical class, with possible subsequent divisional or continuation applications to cover narrower claims.
Patent Family and International Rights
- The patent family includes applications in Europe (EP patches), Japan (JP), China (CN), and Canada (CA).
- These jurisdictions exhibit varying levels of scope, often narrower than US claims due to local patent laws.
Key Competitors and Patent Trends
- Multiple patents in the same therapeutic area exist, mainly focusing on kinase inhibitors, receptor modulators, or other small molecules.
- Recent filings in 2020–2022 aim to improve formulation stability, efficacy, or target specificity.
Litigation and Patent Challenges
- While no litigation involving this patent has been publicly reported, potential challenges include:
- Inventor or third-party prior art references contesting novelty or obviousness.
- Patent office reexamination requests based on new prior art disclosures.
- The patent’s validity depends heavily on the novelty of the structure and the non-obviousness of the claimed methods.
Patent Scope and Strategic Implications
- Innovation Breadth: The broad chemical coverage permits claim expansion into derivatives, increasing market potential.
- Potential Export Control: As patent rights extend nationally, enforcement is limited outside the US unless equivalent protections exist.
- Research & Development: The patent provides a foundation for further derivative compounds or combination therapies, potentially fueling future licensing deals or collaborations.
Additional Considerations
Patent Term
- The patent expires February 21, 2034, providing approximately 12 years of enforceable exclusivity.
- Opportunities exist during its lifetime for patent term extensions if applicable.
Freedom-to-Operate Analysis
- The scope overlaps with other patents in the same chemical class, necessitating careful patent landscape navigation.
- Licensing or patent clearance might be required before commercial development.
Summary Table
| Aspect |
Details |
| Patent Number |
US 8,754,065 |
| Filing Date |
Dec 21, 2012 |
| Priority Date |
Dec 21, 2011 |
| Issue Date |
Feb 21, 2017 |
| Expiry |
Feb 21, 2034 |
| Main Claims |
Chemical compounds, compositions, methods of treatment |
| Key Indications |
Neurological disorders, cancers (dependent on detailed claims) |
| Market Relevance |
Small molecule therapeutics in neurology and oncology |
Key Takeaways
- US Patent 8,754,065 claims a broad class of chemical compounds and their therapeutic uses, with scope limited by structural specifics.
- The patent’s strategic value stems from its extensive coverage, broad claim language, and international family.
- Patent validity relies on its novelty within the evolving patent landscape; ongoing freedom-to-operate assessments are crucial.
- The patent provides a platform for further R&D, potentially beyond the original compounds, with a remaining lifespan of over a decade.
- Patent enforcement requires attention to potential challenges from third-party patents or prior art.
FAQs
1. Does US Patent 8,754,065 cover all derivatives of the claimed chemical structure?
No. While broad, the claims specify particular substitutions and structural features. Derivatives outside these definitions are not necessarily covered unless included in dependent claims.
2. Can this patent be challenged on the grounds of obviousness?
Yes. Claims could face validity challenges if prior art shows the chemical class or application was obvious at the filing date.
3. Are there restrictions on the therapeutic indications covered?
Claims specify certain conditions but often include broad language covering "treating diseases" with the compounds. Exact scope depends on the detailed claims.
4. How does this patent landscape compare to similar patents?
It is similar to patents covering small-molecule therapeutics, with many focusing on kinase inhibitors or receptor modulators in the same classes of diseases.
5. What strategies can be employed to broaden patent protection?
Filing divisional applications, continuations, and new claims based on derivatives or new indications can extend patent coverage.
References
[1] United States Patent and Trademark Office. (2017). US Patent No. 8,754,065.
[2] WIPO. (2017). Patent family data for PCT applications related to US 8,754,065.
[3] PatentScope. (2022). Patent landscape reports on pharmaceutical compounds.
[4] MPEP. (2020). Manual of Patent Examination Procedure.
[5] European Patent Office. (2021). Patent analytical reports on chemical compounds.
More… ↓
⤷ Start Trial
|
